 | Why Need to Watch: Cytokinetics, Incorporated (NASDAQ:CYTK), Comcast … Cytokinetics, Incorporated (NASDAQ:CYTK) on 30 July reported total research and development revenues for the second quarter of 2014 were $ 7.8 million, compared to $ 1.0 million during the same period in 2013. The net loss for the second quarter was $ 8.4 … Read more on […] |
Why Need to Watch: Cytokinetics, Incorporated (NASDAQ:CYTK), Comcast …
↧
↧
Latest Images
Trending Articles
More Pages to Explore .....